PLSE
PULSE BIOSCIENCES, INC. · Healthcare · Market cap $3.8B
Insiders bought $200K net in the last 90 days ·0 sellers, 1 buyer· latest Form 4 filed Sep 2, 2026
Insider Buying
$13.5M
reported purchases (SEC code P)
Insider Selling
$3.4M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Latest filing
Sep 2, 2026
Teplitsky Liane Rae
PULSE BIOSCIENCES, INC. (PLSE) has 11 SEC Form 4 filings (28 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Sep 2, 2026.
Inside the rolling window, 4 insiders at PULSE BIOSCIENCES, INC. reported 6 open-market purchases totaling $13.5M and 10 open-market sales totaling $3.4M. The most active filer is Chief Commercial Officer Danahy Kevin Patrick with 10 filings. Insiders have net bought $13.5M over the trailing 6 months. The largest single insider purchase in this window was $13.0M by Director, 10% Owner DUGGAN ROBERT W on May 11, 2026. The most recent open-market filing is a purchase of 1,024 shares by Chief Operating Officer Teplitsky Liane Rae, dated Aug 31, 2026, worth $50K.
- Industry:Medical - Instruments & Supplies
- CEO:Paul Arthur LaViolette
- Employees:116
- HQ:Miami, FL, US
- IPO:2016-05-18
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Operating Officer | Purchase | 1,024 | $50K | Sep 2 | +2.3% | SEC ↗ | |
| Chief Operating Officer | Purchase | 1,001 | $50K | Sep 2 | +2.3% | SEC ↗ | |
Teplitsky Liane RaeFirst filing | Chief Operating Officer | Purchase | 1,036 | $50K | Aug 28 | +13.2% | SEC ↗ |
Teplitsky Liane RaeFirst filing | Chief Operating Officer | Purchase | 1,034 | $50K | Aug 28 | +13.2% | SEC ↗ |
| Director, 10% Owner | Purchase | 660,233 | $13.0M | May 15 | +119.4% | SEC ↗ | |
| Chief Executive Officer | Purchase | 15,000 | $295K | May 12 | +131.2% | SEC ↗ | |
| Chief Commercial Officer | Sale | 5,000 | $118K | Feb 23 | +166.8% | SEC ↗ | |
| Chief Commercial Officer | Sale | 20,000 | $467K | Feb 17 | +127.6% | SEC ↗ | |
| Chief Commercial Officer | Sale | 20,000 | $471K | Feb 17 | — | SEC ↗ | |
| Chief Commercial Officer | Sale | 20,000 | $473K | Feb 17 | — | SEC ↗ | |
Danahy Kevin PatrickFirst in 4 months | Chief Commercial Officer | Sale | 20,000 | $429K | Feb 11 | — | SEC ↗ |
Danahy Kevin PatrickFirst in 4 months | Chief Commercial Officer | Sale | 20,000 | $470K | Feb 11 | — | SEC ↗ |
Danahy Kevin PatrickFirst in 4 months | Chief Commercial Officer | Sale | 20,000 | $504K | Feb 11 | — | SEC ↗ |
| Chief Commercial Officer | Sale | 4,600 | $85K | Oct 7 | — | SEC ↗ | |
Danahy Kevin PatrickFirst filing | Chief Commercial Officer | Sale | 20,000 | $370K | Sep 22 | — | SEC ↗ |
Danahy Kevin PatrickFirst filing | Chief Commercial Officer | Sale | 400 | $7K | Sep 22 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does PLSE have?
PULSE BIOSCIENCES, INC. (PLSE) has 11 SEC Form 4 filings (28 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Sep 2, 2026.
When was the most recent SEC Form 4 filing for PLSE?
The most recent Form 4 filing for PLSE on Tracefour is dated Sep 2, 2026.
Who is the most active insider at PLSE?
The most active SEC Form 4 filer at PLSE in the rolling window is Chief Commercial Officer Danahy Kevin Patrick, with 10 filings.
What is the net insider flow at PLSE over the last 6 months?
Over the trailing 180 days, insiders at PLSE have net bought $13.5M based on SEC Form 4 disclosures.
What was the largest insider purchase at PLSE?
The largest single insider open-market purchase at PLSE in the rolling window was $13.0M by Director, 10% Owner DUGGAN ROBERT W on 2026-05-11.
What is the total insider buy and sell value at PLSE in the current window?
Inside the rolling window, insiders at PLSE bought $13.5M and sold $3.4M based on SEC Form 4 filings.
Can I get alerts for PLSE insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at PULSE BIOSCIENCES, INC. (PLSE). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
PULSE BIOSCIENCES, INC. is in the Healthcare sector.